REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto De Servicios Integrales En Cancer De Colombia Sas (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Instituto De Servicios Integrales En Cancer De Colombia Sas Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Instituto De Servicios Integrales En Cancer De Colombia Sas is an enterprise based in Colombia. Its main office is in Popayan. The enterprise operates in the General Medical and Surgical Hospitals industry. The company was established on June 16, 2020. In its most recent financial highlights, the company reported a net sales revenue increase of 69.34% in 2025. There was a total growth of 127.22% in Instituto De Servicios Integrales En Cancer De Colombia Sas’s total assets over the same period. In, 2025, the company’s net profit margin increased by 1.97%.

Headquarters
Carrea 6 Nro. 18N - 18
Popayan; Cauca;

Contact Details: Purchase the Instituto De Servicios Integrales En Cancer De Colombia Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Instituto De Servicios Integrales En Cancer De Colombia Sas report to view the information.
Financial Auditors:
Purchase the Instituto De Servicios Integrales En Cancer De Colombia Sas report to view the information.
Incorporation Date:
June 16, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto De Servicios Integrales En Cancer De Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
69.34%
Total Operating Revenue
69.34%
Operating Profit
-43.39%
EBITDA
-43.11%
Net Profit/Loss for the Period
237.45%
Total Assets
127.22%
Total Equity
464.37%
Operating Profit Margin
-20.24%
Net Profit Margin
1.97%
Return on Equity (ROE)
-24.74%
Debt / Equity
1.12%
Quick Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?